Oncolytics Biotech Enters Preliminary Collaboration With The Global Coalition For Adaptive Research
Oncolytics Biotech Enters Preliminary Collaboration With The Global Coalition For Adaptive Research
Oncolytics Biotech 進入與全球適應性研究聯盟的初步合作
The purpose of the preliminary collaboration is to commence planning activities for the evaluation of pelareorep in the treatment of first-line metastatic pancreatic ductal adenocarcinoma (PDAC) as part of GCAR's anticipated master protocol for metastatic pancreatic cancer.
初步合作的目的是開始規劃活動，評估pelareorep在治療一線轉移性胰腺導管腺癌（PDAC）中的作用，這是GCAR預期的轉移性胰腺癌總體方案的一部分。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。